Company Filing History:
Years Active: 2016-2023
Title: The Innovative Contributions of Anatoli Gleiberman
Introduction
Anatoli Gleiberman is a notable inventor based in East Aurora, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 5 patents, Gleiberman's work focuses on utilizing toll-like receptor agonists to combat cancer and protect liver health.
Latest Patents
Gleiberman's latest patents include groundbreaking methods and agents for treating cancer in Toll-Like Receptor 5-expressing tissues. His inventions involve the use of a Toll-Like Receptor agonist, such as flagellin, which has shown promise in enhancing cancer treatment efficacy. Additionally, his patents address the protection of the liver from toxicity associated with cancer treatments, showcasing his commitment to improving patient outcomes.
Career Highlights
Anatoli Gleiberman is associated with Cleveland Biolabs, Inc., where he continues to advance his research in cancer therapies. His work has garnered attention in the scientific community, contributing to the understanding of immune responses in cancer treatment.
Collaborations
Gleiberman has collaborated with esteemed colleagues, including Lyudmila Burdelya and Andrei V Gudkov. These partnerships have further enriched his research and expanded the impact of his inventions in the medical field.
Conclusion
Anatoli Gleiberman's innovative work in cancer treatment through toll-like receptor agonists highlights his dedication to advancing medical science. His contributions are paving the way for new therapeutic approaches that could significantly benefit patients facing cancer.